A Swedish startup aims to dominate stem cell production while nanotechnology is helping to transform cancer care. What does ...

Sana Biotechnology Inc. (NASDAQ:SANA) is one of the best emerging technology stocks to invest in. On December 8, Sana ...

NEW YORK – In an innovative move, a biotech company has found a new way of making stem cells without destroying embryos, touting it as a way to defuse one of the country’s fiercest political and ...

EUDA Health Holdings Limited, a Singapore-based health technology company, has announced preliminary discussions with Guangdong Cell Biotech Co. Ltd., a leader in stem cell therapies and regenerative ...

Renowned Harvard geneticist and serial entrepreneur George Church is at it again, with a venture that has raised $75 million from investors. Church’s biotech company GC Therapeutics launched on ...

Hope is preparing for close-out meetings with the FDA. Chang said the team is “hopeful to advance to a phase 3 confirmatory trial” of the stem cell therapy candidate.

Sana Biotechnology, Inc. stock will be surging today after the company showed it can safely administer its allogeneic cell therapy for diabetes to a patient with no immunosuppression. Engineered cells ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Want to stay on top of ...

As 2025 ends, delve into some biotech feel-good stories where the right treatment meets the right patient, almost feeling ...

Small and mid-cap biotech stocks entered 2025 like a compressed spring, and it finally snapped higher— here's why.

Zephyrm Bioscience is gusting toward the Hong Kong stock exchange, filing (PDF) for an IPO to bankroll phase 3 trials of its cell therapy in a lung condition and graft-versus-host disease (GvHD).

The NASDAQ Biotechnology Index (INDEXNASDAQ:NBI) is trading at three year highs despite market volatility, responding to ...